July 19, 2024

Western Blotting Market Insight: Unraveling Precision in Proteomics

Western Blotting Market

Market Overview:
Western blotting, also known as protein immunoblotting, is a widely used analytical technique used to detect specific proteins in a sample of tissue homogenate or extract. It uses gel electrophoresis to separate native or denatured proteins by the length of the polypeptide chain. The separated proteins are then transferred to a membrane, where they are probed with antibodies specific to the target protein. Antibodies conjugated to enzymes are often used to detect and visualize the bound antibodies on the membrane. This allows researchers and scientists to qualitatively analyze the expression of specific proteins and modifications in various cells and tissues. The technique is commonly used in biomedical research to study gene and protein expression, post-translational modifications, and verify the presence of specific proteins in cells or tissues.

The global Western Blotting Market is estimated to be valued at US$ 759.5 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
One of the key trends in the Western blotting market is the increasing focus on protein biomarker discovery for various diseases. Biomarkers play an important role in drug development and clinical diagnosis. Western blotting technique allows researchers to study protein expression patterns and identify potential protein biomarkers. This has driven research activity in disease protein biomarkers for conditions like cancer, Alzheimer’s, Parkinson’s etc. Additionally, growing proteomics research worldwide is also boosting the demand for western blotting kits, reagents and instruments. Technological advancements in western blotting methods have improved protein separation, detection and made the process more accurate and quantitative. This is expected to support the growth of the western blotting market during the forecast period.
Porter’s Analysis
Threat of new entrants: The western blotting market requires high initial investments and licenses as significant R&D is required for developing new techniques and antibodies. This poses high entry barriers for new players.

Bargaining power of buyers: Buyers have moderate bargaining power in the western blotting market due to the availability of substitutes and dominance of few global leaders. However, specialized nature of products maintains buyers dependence on some suppliers.

Bargaining power of suppliers: Suppliers have high bargaining power due to specialized nature of raw materials like antibodies, reagents, instruments and membranes required to develop western blotting products. This limits options for buyers.

Threat of new substitutes: Techniques like immunohistochemistry, ELISA and flow cytometry offer substitutes with varied capabilities. However, western blotting is used widely in research and is not likely to be replaced completely due to its effectiveness in protein analysis.

Competitive rivalry: Intense due to presence of global dominant players and scientific advances requiring huge investments.

Key Takeaways
The global western blotting market is expected to witness high growth, exhibiting CAGR of 6.8% over the forecast period, due to increasing research activity in life sciences.

Regional analysis: North America dominates the market accounting for over 40% share due to presence of leading players and high research expenditure. Asia Pacific is expected to witness fastest growth during the forecast period supported by increasing investments from government as well as private players in countries like China and India.

Key players operating in the western blotting market are Thermo Fisher Scientific, Inc., GE HealthCare, F. Hoffmann-La Roche Ltd, Lumigen, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., LI-COR, Inc., Bio-Techne, SBH Sciences, Advansta Inc., Azure Biosystems Inc., HiMedia Laboratories., Elabscience Biotechnology Inc., GenScript, Cell Signaling Technology, Inc., ICL, Inc., Takara Bio Inc., Leinco Technologies

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it